Pharmafile Logo
Pharmafocus logo
Advanced Search

biotech

Showing 15 posts of 861 posts found.

Cellbyte raises $2.75m to fund pharma drug launch platform

November 27, 2025
Product launch AI, Cellbyte, biotech

Cellbyte has announced that it has raised $2.75m in seed funding for the streamlining of pharmaceutical drug launches. The complexity …

News

Richmond Pharmacology appoints Dr Edward Jackson as Medical Director

November 7, 2025
CRO, Richmond Pharmacology, biotech, clinical trials

Richmond Pharmacology, a contract research organisation (CRO) specialising in first-in-human and adaptive clinical trials, has appointed Dr Edward Jackson as …

Appointment

Lilly opens fourth US Gateway Labs site

September 26, 2025
Research and Development Eli Lilly, Local Investment, biotech, life sciences

Eli Lilly has opened its newest Lilly Gateway Labs (LGL) site in San Diego, California, expanding its network of shared …

News
drug-trials

LGC Group opens $100M Organic Chemistry Synthesis Centre of Excellence

September 19, 2025
Medical Communications, Research and Development LGC Group, biotech, life sciences, pharma

LGC Group, a life sciences company, has opened its new Organic Chemistry Synthesis Centre of Excellence in Ontario, Canada after …

News
Lilly secures conditional MHRA approval for new blood cancer treatment

Crown Bioscience opens new US model development centre

September 19, 2025
Medical Communications, Research and Development CRO, biotech, crown bioscience, life sciences

Crown Bioscience, a US global contract research organisation (CRO) that is part of JSR Life Sciences and Japan-based JSR Corporation, …

News

Sapio Sciences and Ultima Genomics form multi-omics research partnership

September 11, 2025
Medical Communications, Research and Development Sapio Sciences, Ultima Genomics, biotech, genomics research

Sapio Sciences and Ultima Genomics have formed a strategic partnership to accelerate genomics research. The collaboration aims to make multi-omics …

News
drug-trials

MultiOmic Health and BIO4 Campus sign collaborative Memorandum of Understanding

September 8, 2025
Medical Communications, Research and Development AI, BIO4 Campus, Memorandum of Understanding, MultiOmic Health, biotech

MultiOmic Health (MOH), an artificial intelligence (AI)-enabled precision medicine biotechnology company and BIO4 Campus (BIO4), a biotechnology and life sciences …

News
Publishing image

ANGLE’s Parsortix system used in new cancer biology research

June 10, 2025
Medical Communications, Research and Development Angle, Oncology, Parsortix system, R&D, biotech, oncology, scientific journals

ANGLE has announced three new peer-reviewed publications demonstrating the use of its Parsortix circulating tumour cell (CTC) harvesting system in …

News
shaking-hands-gb7ac17374_1920

Neogap Therapeutics selected to join EIC Soft-landing Programme, supporting international growth

May 15, 2025
Medical Communications, Sales and Marketing Corporate, European Innovation Council (EIC), Immunology, Neogap Therapeutics, US pharma market, biotech, immunotherapy

Swedish biotech company, Neogap Therapeutics, has been selected to participate in the EIC Soft-landing Programme for Healthcare and Life Sciences …

News

Terumo’s plasma donation system adopted by Join Parachute to expand access to lifesaving therapies

May 13, 2025
Biotech/start-up, Sales and Marketing Haematology, Join Parachute, Pharmacy, Terumo Blood and Cell Technologies (Terumo BCT), biotech, plasma donation

US Biotech company, Terumo Blood and Cell Technologies (Terumo BCT), has announced that Join Parachute will adopt its Rika Plasma …

News

Neogap chosen for Innovate Nordics 2025 Acceleration Programme

May 1, 2025
Research and Development Innovate Nordics, Neogap Therapeutics, Oncology, biotech, funding programme, immunotherapy

Swedish biotech company Neogap Therapeutics has been chosen to join Innovate Nordics’ 2025 acceleration programme, a prestigious initiative designed to …

News

Neurizon makes appointments to executive team

April 24, 2025
Recruitment, Senior Management Neurizon, Neurology, als, biotech, neurodegenerative diseases

Neurizon Therapeutics, a clinical-stage biotech company focusing on treatments for neurodegenerative diseases, has announced three leadership appointments. These will support …

Appointment

Successful trial results announced for potential rare eye disease treatment

April 14, 2025
Research and Development Eyestem, Opthalmology, age-related macular degeneration (AMD), biotech, cell therapy, eye disease

Eyestem Research, an Indian biotech company, announced successful results from its phase 1 trial of Eyecyte-RPE, a potential therapy for …

News

Infinitopes launches first-in-human trial of vaccine targeting oesophageal cancer

April 9, 2025
Research and Development Infinitopes, Oncology, biotech, oesophageal cancer, oncology

The cancer biotech company Infinitopes has gained approval by the UK Medicines and Healthcare products Regulatory Agency (MHRA) to evaluate …

News

GRI Bio announces two global patents granted for Europe and Japan

April 2, 2025
Research and Development Chronic Diseases, GRI Bio, autoimmune diseases, biotech, fibrotic diseases, inflammatory diseases, patent

GRI Bio, a biotech company that specialises in treatment for inflammatory, fibrotic and autoimmune diseases, has announced that two global …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025